Nontuberculous Mycobacterium Infection Clinical Trial
Official title:
A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection
The purpose of this study is to evaluate the efficacy and safety of open-label exposure of gNO in patients with NTM lung disease. Subjects will receive the study drug by inhaling through a nasal mask. Subjects will be treated for 3 weeks (5 days per week) and followed monthly for 3 months.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT03532438 -
WGS of NTM From Sputum of NTM Lung Disease Patients and From Their Environments
|
||
| Recruiting |
NCT04921943 -
Hypertonic Saline for MAC
|
Phase 4 | |
| Recruiting |
NCT04294043 -
IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)
|
Phase 1 | |
| Recruiting |
NCT05280886 -
Multi-site Cohort Study for the Development of Personalized Pharmacotherapy in Patients With Tuberculosis (TB)
|
||
| Completed |
NCT04024423 -
Healthcare-associated Links in Transmission of Nontuberculous Mycobacteria in Cystic Fibrosis
|
||
| Active, not recruiting |
NCT06004037 -
Study to Evaluate the Efficacy of Delpazolid as Add-on Therapy in Refractory Mycobacterium Abscessus Complex
|
Phase 2 | |
| Enrolling by invitation |
NCT06262282 -
Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria
|
||
| Recruiting |
NCT03672630 -
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
|
Phase 2/Phase 3 | |
| Recruiting |
NCT03120481 -
Controls for Respiratory Diseases
|
N/A |